Bath & Body Works, Inc. $BBWI Shares Purchased by IFP Advisors Inc

IFP Advisors Inc grew its position in Bath & Body Works, Inc. (NYSE:BBWI) by 148.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,974 shares of the company’s stock after acquiring an additional 2,971 shares during the quarter. IFP Advisors Inc’s holdings in Bath & Body Works were worth $149,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in BBWI. SVB Wealth LLC bought a new stake in Bath & Body Works during the first quarter valued at $35,000. Geneos Wealth Management Inc. lifted its holdings in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the last quarter. Parallel Advisors LLC boosted its stake in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after acquiring an additional 481 shares during the period. Golden State Wealth Management LLC grew its holdings in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. Finally, GKV Capital Management Co. Inc. acquired a new stake in shares of Bath & Body Works during the 1st quarter worth approximately $69,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Telsey Advisory Group reiterated an “outperform” rating and issued a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $26.00 target price on shares of Bath & Body Works in a research report on Monday, October 6th. Morgan Stanley cut their price target on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a report on Friday, September 12th. Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Finally, UBS Group cut their target price on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research note on Friday, August 29th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $37.46.

Bath & Body Works Stock Up 1.9%

NYSE:BBWI opened at $26.50 on Friday. The business’s 50-day moving average price is $27.73 and its 200 day moving average price is $29.10. Bath & Body Works, Inc. has a 52-week low of $24.85 and a 52-week high of $41.87. The firm has a market cap of $5.46 billion, a P/E ratio of 7.86, a PEG ratio of 0.91 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. Bath & Body Works’s revenue was down .8% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.0%. Bath & Body Works’s dividend payout ratio is currently 23.74%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.